Satavaptan (SR121463) ( DrugBank: Satavaptan )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
72	下垂体性ADH分泌異常症	1

72. 下垂体性ADH分泌異常症

---

臨床試験数 : 41 /  薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00728091 (ClinicalTrials.gov)	July 2008	31/7/2008	A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Satavaptan (SR121463B) Versus Placebo in Patients With Dilutional Hyponatremia Due to the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)	Hyponatremia;Inappropriate ADH Syndrome	Drug: satavaptan (SR121463);Drug: placebo	Sanofi	NULL	Terminated	18 Years	N/A	Both	2	Phase 3	United States